Telehealth has been held up as a prime strategy to cut down on carbon emissions from the health care systems. But there still isn’t good evidence on its trade-offs.
Two congenitally deaf children can hear after being treated with a gene therapy, according to new data from an ongoing clinical trial.
The FDA nod means trial sponsors can use Apple Watch’s A-fib history as a secondary endpoint in trials without having to do additional work.
The immense potential benefits of biotechnology are profoundly vulnerable to misuse. Better screening of synthetic DNA orders is a key barrier to bad actors.
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
Nominate a 2024 STAT Wunderkind STAT Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program
“We’ve sort of anthropomorphized AI and said it has to be a thing that’s going to replace a human. Why are we not reenvisioning that…
Dairy farmers’ reluctance to report H5N1 infections among cows or allow testing of their workers is complicating the public health response to the bird flu.
Members of Congress appear likely to opt for a short-term extension of Medicare telehealth policies instead of permanent changes.
STAT’s Casey Ross and Bob Herman have been named 2024 Pulitzer Prize finalists. Read executive editor Rick Berke’s note to readers on the honor.
